Silence Therapeutics (SLN)

185.50p
   
  • Change Today:
      7.50p
  • 52 Week High: 312.50
  • 52 Week Low: 37.50
  • Currency: UK Pounds
  • Shares Issued: 47.01m
  • Volume: 80,278
  • Market Cap: £87.21m
  • RiskGrade: 310
  • Beta: 0.93

SLN Overview

Silence Therapeutics is in the pharmaceuticals & biotechnology sector and is currently trading at 185.50p per share. In the last year Silence Therapeutics's share price has ranged from 37.50p to 312.50p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -834.2% -11239.2%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 125.7 368.0
Pr/Book 2.7  
Latest F'cast
Revenue -70.7% -65.8%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

SLN Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-07 4.05 (5.24) (195.05)p n/a n/a n/a n/a 0.0%
31-Dec-08 2.21 (7.43) (275.47)p n/a n/a n/a n/a 0.0%
31-Dec-09 1.72 (7.51) (246.59)p n/a n/a n/a n/a 0.0%
31-Dec-10 2.37 (8.80) (140.40)p n/a n/a n/a n/a 0.0%
31-Dec-11 0.69 (5.74) (51.49)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SLN Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 0.24 (26.64) (135.00)p n/a n/a n/a n/a 0.0%
31-Dec-13 3.28 (3.67) (9.50)p n/a n/a n/a n/a 0.0%
31-Dec-14 1.00 (6.37) (17.00)p n/a n/a n/a n/a 0.0%

Copyright © 2013 FactSet Research Systems Inc. All rights reserved.

SLN Company Announcements

Holding(s) in Company 02-May-2013 16:52 RNS
Holding(s) in Company 02-May-2013 15:55 RNS
Holding(s) in Company 02-May-2013 15:52 RNS

Latest SLN Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

SLN Market Data

Currency UK Pounds
Share Price 185.50p
Change Today 7.50p
% Change 4.21 %
52 Week High 312.50
52 Week Low 37.50
Volume 80,278
Shares Issued 47.01m
Market Cap £87.21m
Beta 0.93
RiskGrade 310

SLN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.61% below the market average33.61% below the market average33.61% below the market average33.61% below the market average33.61% below the market average
13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average
Price Trend
76.82% above the market average76.82% above the market average76.82% above the market average76.82% above the market average76.82% above the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average
Income Not Available
Growth
63.42% below the market average63.42% below the market average63.42% below the market average63.42% below the market average63.42% below the market average
74.36% below the sector average74.36% below the sector average74.36% below the sector average74.36% below the sector average74.36% below the sector average

SLN Dividends

No dividends found

Trades for 24-May-2013

Time Volume / Share Price
15:57 1,200 @ 185.00p
15:34 15,000 @ 184.00p
12:24 21 @ 183.20p
10:02 1,000 @ 185.00p
10:02 1,000 @ 186.00p

SLN Key Personnel

Finance Director Tim Freeborn

Top of Page